D-1017-2020 Class II Terminated

Recalled by Perrigo Company PLC — Allegan, MI

FDA drug recall D-1017-2020 was initiated by Perrigo Company PLC on Oct 23, 2019 and is designated Class II. Reason for recall: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. The recall status is terminated (terminated Nov 6, 2020).

Recall details

Product Type
Drugs
Report Date
Mar 25, 2020
Initiation Date
Oct 23, 2019
Termination Date
Nov 6, 2020
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 8 tablets. [NDC: Brand] NDC Good Sense:0113-0852-51; NDC Walgreens 0363-0852-51

Reason for recall

CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Distribution pattern

Nationwide USA

Code information

Lots: 8CE1429, 8CE1760, 9BE2907, 9DE3183, 9EE2900, 9JE2936

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1017-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1017-2020. Report a data issue: hello@regdatalab.com.